An AMP-activated protein kinase-PGC-1α axis mediates metabolic plasticity in glioblastoma.

Autor: Sauer B; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, a partnership between DKFZ and University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany., Kueckelhaus J; Microenvironment and Immunology Research Laboratory, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Medicine and Medical Center, Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany., Lorenz NI; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, a partnership between DKFZ and University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany., Bozkurt S; Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany., Schulte D; Institute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Weinem JB; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, a partnership between DKFZ and University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany., Benzarti M; Cancer Metabolism Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, 2 avenue de Université, Esch-sur-Alzette, Luxembourg., Meiser J; Cancer Metabolism Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, 2 avenue de Université, Esch-sur-Alzette, Luxembourg., Urban H; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, a partnership between DKFZ and University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany., Villa G; Microenvironment and Immunology Research Laboratory, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Medicine and Medical Center, Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany., Harter PN; Institute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and Ludwig-Maximilians-Universität (LMU), Munich, Germany.; Center for Neuropathology and Prion Research, Faculty of Medicine, Ludwig-Maximilians-Universität (LMU), Munich, Germany., Münch C; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.; Cardio-Pulmonary Institute, Goethe University Frankfurt, Frankfurt am Main, Germany., Rieger J; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; Division of Neuro-Oncology, Hertie Institute of Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany., Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, a partnership between DKFZ and University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany., Heiland DH; Microenvironment and Immunology Research Laboratory, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Medicine and Medical Center, Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany., Ronellenfitsch MW; Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, a partnership between DKFZ and University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2024 Nov; Vol. 14 (11), pp. e70030.

Prévalence du syndrome métabolique dans une population de patients apnéiques : étude prospective avec calcul du risque cardiovasculaire

Autor: Ben Jazia, R., Ben Salem, H., Gargouri, I., Aissa, S., Garrouche, A., Hayouni, A., Benzarti, M., Boussarsar, M., Abdelghani, A.

Publikováno v: In Revue de Pneumologie clinique October 2015 71(5):311-317

Impact de la BPCO sur la qualité de vie et l’état de santé mentale chez cent patients tunisiens

Autor: Maoua, M., El Maalel, O., Abdelghani, A., Boughattas, W., Kalboussi, H., Chatti, S., Bel Hadj Ibrahim, H., Brahem, A., Debbabi, F., Benzarti, M., Mrizak, N.

Publikováno v: In Revue de Pneumologie clinique August 2014 70(4):195-202

Recensement des spores fongiques dans l’atmosphère de la ville de Sousse (Tunisie)

Autor: Gargouri, I., Mezghani, S., Hayouni, A., Njima, H., Abdelghani, A., Garrouch, A., Benzarti, M., Razzouk, H., Jerray, M.

Publikováno v: In Revue Francaise d'Allergologie 2010 50(8):603-610

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.

Autor: Largeot A; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Klapp V; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Viry E; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Gonder S; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Fernandez Botana I; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Blomme A; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium., Benzarti M; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.; Department of Cancer Research, Cancer Metabolism Group, Luxembourg Institute of Health, Luxembourg, Luxembourg., Pierson S; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Duculty C; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Marttila P; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden., Wierz M; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Gargiulo E; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Pagano G; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., An N; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium., El Hachem N; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium., Perez Hernandez D; Department of Infection and Immunity, Proteomics of Cellular Signaling, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Chakraborty S; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Ysebaert L; Haematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., François JH; Laboratoire d'hématologie, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg., Cortez Clemente S; Département d'hémato-oncologie, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg., Berchem G; Département d'hémato-oncologie, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.; Luxembourg Institute of Health, Luxembourg, Luxembourg., Efremov DG; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Dittmar G; Department of Infection and Immunity, Proteomics of Cellular Signaling, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg., Szpakowska M; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Chevigné A; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Nazarov PV; Department of Cancer Research, Multiomics Data Science, Luxembourg Institute of Health, Luxembourg, Luxembourg., Helleday T; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.; Department of Oncology and Metabolism, Weston Park Cancer Centre, The Medical School, University of Sheffield, Sheffield, United Kingdom., Close P; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium.; WELBIO Department, WEL Research Institute, Wavre, Belgium., Meiser J; Department of Cancer Research, Cancer Metabolism Group, Luxembourg Institute of Health, Luxembourg, Luxembourg., Stamatopoulos B; Laboratory of Clinical Cell Therapy, ULB-Research Cancer Center, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium., Désaubry L; Regenerative Nanomedicine Laboratory (UMR1260), Faculty of Medicine, Fédération de Médecine Translationnelle de Strasbourg, INSERM-University of Strasbourg, Strasbourg, France., Paggetti J; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Moussay E; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.

Publikováno v: Blood [Blood] 2023 Jun 29; Vol. 141 (26), pp. 3166-3183.